5‑Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma
Kahl, Dylan J, Hutchings, Kim M, Lisabeth, Erika Mathes, Haak, Andrew J, Leipprandt, Jeffrey R, Dexheimer, Thomas, Khanna, Dinesh, Tsou, Pei-Suen, Campbell, Phillip L, Fox, David A, Wen, Bo, Sun, Duxin, Bailie, Marc, Neubig, Richard R, Larsen, Scott D
Published in Journal of medicinal chemistry (09.05.2019)
Published in Journal of medicinal chemistry (09.05.2019)
Get full text
Journal Article
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Reponse Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma
Kahl, Dylan J., Hutchings, Kim M., Lisabeth, Erika Mathes, Haak, Andrew J., Leipprandt, Jeffrey R., Dexheimer, Thomas, Khanna, Dinesh, Tsou, Pei-Suen, Campbell, Phillip L., Fox, David A., Wen, Bo, Sun, Duxin, Bailie, Marc, Neubig, Richard R., Larsen, Scott D.
Published in Journal of medicinal chemistry (18.04.2019)
Published in Journal of medicinal chemistry (18.04.2019)
Get full text
Journal Article